article thumbnail

How We Built a New Company Culture

Harvard Business Review

I learned this while leading a turnaround of NPS Pharmaceuticals , a biotechnology company that now specializes in creating treatments for rare diseases. To save the 20-year-old company, I had to get it operating like a start-up. NPS had hit a rough patch in 2006. First, let me give you a little background.

article thumbnail

A Quiet Revolution in Clean-Energy Finance

Harvard Business Review

Between 2006 and 2008, more than $1 billion venture-capital dollars were channeled into startups focused on solar, wind and biofuel technologies. Their behavior displays promising parallels to the early days of the biotechnology industry.

Energy 11